In CRC2, three out of the five selected TCRs could specifically recognize autologous tumor cells, as evidenced by the IFN-γ production of these engineered TCR-T cells when incubated with autologous tumor cells (Fig. 5E, supplementary Fig. S4). Here, IFNG is linked to neoplasm.